眼科巨头爱尔康最终完成对Aurion收购,创始人出局

医疗器械创新网
29 Mar

3月26日,眼科巨头爱尔康宣布已成功完成对Aurion Biotech多数股权的收购,并任命原首席科学官Arnaud Lacoste为CEO,接替了创始人Greg Kunst。收购完成后,Aurion Biotech将保持独立运营,爱尔康将提供研发、监管及商业化支持,以加速推进全球首款角膜同种异体细胞疗法AURN001在2025年进入三期临床试验阶段。持续一年的股权纷争似乎已告一段落。纷争起源于...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10